A large study of electronic health records has uncovered four common patterns of medical conditions that tend to unfold in ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance ...

The new dosing schedule with a more gradual titration significantly lowered incidence of ARIA-E in the TRAILBLAZER-ALZ 6 trial.

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...

More than 400 cyclists will be trekking across South Carolina this weekend as part of a three-day cycling challenge to raise money and awareness in the fight to end Alzheimer’s disease.

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Gov. Josh Green signed three bills on Thursday to enhance protections for vulnerable citizens in Hawaii, including one measure focused on helping kupuna living with dementia.

The damage alcohol causes to the brain is both direct and indirect. It directly harms brain cells and interferes with ...

With over 7 million Americans living with this disease, we need to do a better job of equipping primary care physicians with ...

The study investigates the link between pesticide exposure and cognitive impairment in older adults, suggesting a need for ...